Vincent JL - Search Results

1

Higher Fluid Balance Increases the Risk of Death From Sepsis: Results From a Large International Audit.

Sakr Y, Rubatto Birri PN, Kotfis K, Nanchal R, Shah B, Kluge S, Schroeder ME, Marshall JC, Vincent JL; Intensive Care Over Nations Investigators. Sakr Y, et al. Among authors: vincent jl. Crit Care Med. 2017 Mar;45(3):386-394. doi: 10.1097/CCM.0000000000002189. Crit Care Med. 2017. PMID: 27922878

2

Round table conference on clinical trials for the treatment of sepsis.

Sibbald WJ, Vincent JL. Sibbald WJ, et al. Among authors: vincent jl. Crit Care Med. 1995 Feb;23(2):394-9. doi: 10.1097/00003246-199502000-00027. Crit Care Med. 1995. PMID: 7867364

3

How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage.

Cook DJ, Hébert PC, Heyland DK, Guyatt GH, Brun-Buisson C, Marshall JC, Russell J, Vincent JL, Sprung CL, Rutledge F. Cook DJ, et al. Among authors: vincent jl. Crit Care Med. 1997 Sep;25(9):1502-13. doi: 10.1097/00003246-199709000-00017. Crit Care Med. 1997. PMID: 9295824 Review.

4

Issues in contemporary fluid management.

Vincent JL. Vincent JL. Crit Care. 2000;4 Suppl 2(Suppl 2):S1-2. doi: 10.1186/cc964. Epub 2000 Oct 13. Crit Care. 2000. PMID: 11255591 Free PMC article.

5

Platelet function in sepsis.

Vincent JL, Yagushi A, Pradier O. Vincent JL, et al. Crit Care Med. 2002 May;30(5 Suppl):S313-7. doi: 10.1097/00003246-200205001-00022. Crit Care Med. 2002. PMID: 12004253 Review.

6

The epidemiology of acute respiratory failure in critically ill patients(*).

Vincent JL, Akça S, De Mendonça A, Haji-Michael P, Sprung C, Moreno R, Antonelli M, Suter PM; SOFA Working Group. Sequntial organ failure assessment. Vincent JL, et al. Chest. 2002 May;121(5):1602-9. doi: 10.1378/chest.121.5.1602. Chest. 2002. PMID: 12006450

7

Barbiturate coma for intracranial hypertension: clinical observations.

Dereeper E, Berré J, Vandesteene A, Lefranc F, Vincent JL. Dereeper E, et al. Among authors: vincent jl. J Crit Care. 2002 Mar;17(1):58-62. doi: 10.1053/jcrc.2002.33032. J Crit Care. 2002. PMID: 12040550

8

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis.

Angus DC, Linde-Zwirble WT, Clermont G, Ball DE, Basson BR, Ely EW, Laterre PF, Vincent JL, Bernard G, van Hout B; PROWESS Investigators. Angus DC, et al. Among authors: vincent jl. Crit Care Med. 2003 Jan;31(1):1-11. doi: 10.1097/00003246-200301000-00001. Crit Care Med. 2003. PMID: 12544986 Clinical Trial.

9

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis.

Ely EW, Laterre PF, Angus DC, Helterbrand JD, Levy H, Dhainaut JF, Vincent JL, Macias WL, Bernard GR; PROWESS Investigators. Ely EW, et al. Among authors: vincent jl. Crit Care Med. 2003 Jan;31(1):12-9. doi: 10.1097/00003246-200301000-00002. Crit Care Med. 2003. PMID: 12544987 Clinical Trial.

10

Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis.

Root RK, Lodato RF, Patrick W, Cade JF, Fotheringham N, Milwee S, Vincent JL, Torres A, Rello J, Nelson S; Pneumonia Sepsis Study Group. Root RK, et al. Among authors: vincent jl. Crit Care Med. 2003 Feb;31(2):367-73. doi: 10.1097/01.CCM.0000048629.32625.5D. Crit Care Med. 2003. PMID: 12576938 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,459 results

Search Page